Literature DB >> 3958624

Determination of ketone body kinetics using a D-(-)-3-hydroxy[4,4,4-2H3]butyrate tracer.

P F Bougneres, E O Balasse, P Ferré, D M Bier.   

Abstract

In studies where D-(-)-3-hydroxy[4,4,4-2H3]butyrate is employed as isotopic tracer in vivo, we have described a selected ion monitoring, gas-liquid chromatography-mass spectrometry micromethod which measures [2H3] tracer enrichment in 3-hydroxybutyrate and acetoacetate from 300-microliters blood samples. For plasma samples in the physiologic range, intra- and interassay precisions for each ketone averaged better than +/- 1% and +/- 2%, respectively. The use of the method was validated by comparing kinetic data obtained with the above tracer with simultaneous flux data obtained with conventional D-(-)-3-hydroxy[3-14C]butyrate tracer in five fasted rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958624

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes.

Authors:  A Avogaro; R Nosadini; D M Bier; C Cobelli; G Toffolo; A Doria; A Valerio; H Christopherson
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

Review 2.  Flux analysis of inborn errors of metabolism.

Authors:  D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2018-01-09       Impact factor: 4.982

3.  Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency.

Authors:  Willemijn J van Rijt; Johan L K Van Hove; Frédéric M Vaz; Rick Havinga; Derk P Allersma; Tanja R Zijp; Jirair K Bedoyan; M R Heiner-Fokkema; Dirk-Jan Reijngoud; Michael T Geraghty; Ronald J A Wanders; Maaike H Oosterveer; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.